Innovage Holding (INNV) reported $854M in revenue for fiscal 2025, +11.8% year on year. That ranks #1871 by revenue among 2853 SEC filers and #174 in Healthcare. It posted a net loss of −$30.3M for the same year. Revenue has grown 8.5% a year on average since 2020 ($567M then). The fiscal 2025 balance sheet shows $527M in total assets, $83.2M in cash and $56.0M in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $854M | +11.8% | FY20252025-06-30 |
| Gross profitGrossProfit | $154M | +16.3% | FY20252025-06-30 |
| Operating incomeOperatingIncomeLoss | −$29.8M | −$6.6M | FY20252025-06-30 |
| Net incomeNetIncomeLoss | −$30.3M | −$9.0M | FY20252025-06-30 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $32.9M | +$69.8M | FY20252025-06-30 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $6.3M | −20.9% | FY20252025-06-30 |
| Total assetsAssets | $527M | +0.5% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $257M | +3.4% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $83.2M | +80.6% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $56.0M | −6.4% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $252M | −$29.5M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Profile
- Legal name
- Innovage Holding Corp.
- Ticker
- INNV
- Exchange
- Nasdaq
- SIC classification
- Services-Health Services (8000)
- Fiscal year end
- 06-30
- CIK
- 0001834376
Filings
- 10-KSep 9, 2026Open filing →
- 10-QMay 8, 2026Open filing →
- 10-QFeb 3, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Warby ParkerWRBY | $872M | $1.6M |
| NeogenNEOG | $870M | −$7.9M |
| Harmony BiosciencesHRMY | $868M | $159M |
| Innovage HoldingINNV | $854M | −$30.3M |
| Arrowhead PharmaceuticalsARWR | $829M | −$1.6M |
| Myriad GeneticsMYGN | $825M | −$366M |
| Orthofix MedicalOFIX | $822M | −$92.2M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Innovage Holding — Key figures |url=https://companiesranked.com/en/company/innovage-holding |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Innovage Holding — Key figures. CompaniesRanked. https://companiesranked.com/en/company/innovage-holdingBibTeX
@misc{companiesranked-en-company-innovage-holding-2026,
author = {{CompaniesRanked}},
title = {{Innovage Holding — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/innovage-holding}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001834376-26-000049 · September 9, 2026
{{cite web |title=Innovage Holding — Key figures — 10-K (0001834376-26-000049) |url=https://www.sec.gov/Archives/edgar/data/1834376/000183437626000049/innv-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-09-09}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.